DHB — Delivra Health Brands Cashflow Statement
0.000.00%
- CA$9.38m
- CA$7.99m
- CA$9.79m
- 39
- 64
- 85
- 67
Annual cashflow statement for Delivra Health Brands, fiscal year end - June 30th, CAD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -28 | -81.4 | -28.5 | -7.01 | -0.184 |
Depreciation | |||||
Non-Cash Items | 12.7 | 63.8 | 18.5 | 1.76 | -0.858 |
Discontinued Operations | |||||
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -5.58 | -3.87 | -2.25 | -1.31 | -1.38 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Payable / Accrued Expenses | |||||
Cash from Operating Activities | -20 | -18.4 | -9.65 | -4.44 | -1.09 |
Capital Expenditures | -11.3 | -6.32 | -0.033 | -0.022 | -0.041 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -6.06 | 2.68 | 12.3 | 1.37 | 2.95 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -17.3 | -3.64 | 12.3 | 1.35 | 2.91 |
Financing Cash Flow Items | 0.5 | 0 | 4.49 | 0 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.76 | 3.17 | 0.446 | -0.309 | -0.255 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -36.5 | -18.9 | 3.02 | -3.35 | 1.64 |